Historical catalog analysis: CISA added this entry on March 05, 2026. The entry reflects catalog information retrieved on August 31, 2026, not a snapshot archived on the inclusion date. Check current vendor guidance before acting.
What the vulnerability is
CVE-2023-41974 is a use-after-free vulnerability (CWE-416) identified in Apple iOS and iPadOS. This flaw could allow a malicious application to execute arbitrary code with kernel privileges, representing a high level of system access on the affected mobile platforms.
Exposure and applicability
This vulnerability is applicable to healthcare organizations that deploy iPhones or iPads for clinical workflows, such as bedside charting, telehealth, or secure messaging. Because these devices often handle electronic Protected Health Information (ePHI), a kernel-level compromise could potentially bypass standard application sandboxing, increasing the risk to data integrity and confidentiality on the device.
Remediation priorities
Our analysis suggests that healthcare security leaders prioritize the following actions based on their mobile device management (MDM) strategy:
- Inventory Identification: Identify all managed iOS and iPadOS devices currently in use across clinical and administrative environments to determine which are running affected versions.
- Vendor Patch Deployment: Apply the updates provided by Apple as specified in their official security documentation. This is the primary method for addressing the underlying code flaw.
- Application Review: While patching the OS is the priority, organizations should review the permissions of third-party applications installed on clinical devices to ensure only authorized software is present, reducing the potential surface for an app-based exploit.
How to validate remediation
To verify that exposure has been reduced, security teams can use the following methods:
* Version Audit: Use MDM dashboards to generate a report confirming that all active devices have been updated to a version where CVE-2023-41974 is addressed.
* Compliance Check: Verify through MDM policy enforcement that devices failing to meet the minimum OS version requirement are flagged or restricted from accessing corporate ePHI repositories until they are updated.
Limits and open questions
Updating the operating system could reduce the likelihood of exploitation, but it does not guarantee total immunity from all mobile threats. It remains unknown whether this vulnerability has been utilized in ransomware campaigns. Additionally, while CISA has established a remediation deadline for federal agencies, private healthcare providers must determine their own patching timelines based on their internal risk management processes and clinical operational requirements.
Source and editorial note
CVE-2023-41974: Apple iOS and iPadOS Use-After-Free Vulnerability · Source date: March 05, 2026 · Retrieved August 31, 2026.
Material facts are tied to the cited primary source. Recommendations are independent defensive analysis unless attributed to the source. Confirm consequential decisions against current authoritative guidance.
Archive date: March 08, 2026. The displayed post date is assigned three days after the source date to organize this retrospective archive; it does not mean this site published the analysis then. First published by this site: September 16, 2026 at 01:12 UTC.
Request a healthcare security assessment
Turn healthcare security intelligence into action.
Discuss your environment, priorities, and the evidence needed to validate safeguards.
Request a healthcare assessment ↗